FTC intends to block an acquisition involving Edwards Lifesciences due to competitive concerns.
6 reports, 5 independent
Updated Jul 24
Gone quiet
Reached 4 outlets in its first 24 hours
- Reports
- 6
- Developments
- 1
- Repetition
- 83%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FTC intends to block an acquisition involving Edwards Lifesciences due to competitive concerns.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Edwards Lifesciences
American medical technology company
-
Federal Trade Commission
United States federal government agency
Related events
Coverage
Newest first; wire copies grouped- yahoo.comEdwards Lifesciences (EW) Stock Looks Fair On Cash Flow While Earnings Trade At A Premium
- Medical Device NetworkFTC to block Edwards Lifesciences’ acquisition of JenaValve due to competitive concerns The Federal Trade Commission (FTC) recently announced its intention to block Edwards Lifesciences’ acquisition
- ReutersFTC seeks to block Edwards Lifesciences' acquisition of JenaValve (Reuters) -The U.S. Federal Trade Commission has sued to block Edwards Lifesciences Corp's acquisition of JenaValve Technology Inc, s
- Medical Device NetworkFTC files lawsuit to halt Edwards acquisition of JenaValve The US Federal Trade Commission (FTC) is suing Edwards Lifesciences to prevent it from acquiring JenaValve, citing anticompetitive concerns.
- Business WireEdwards Lifesciences Comments on FTC’s Action to Block Proposed Acquisition of JenaValve IRVINE, Calif., August 06, 2025--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) announced today that the U.S
- GlobeNewswireJenaValve Responds to FTC’s Action Against Proposed Edwards Lifesciences Acquisition IRVINE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology announced today that the U.S. Federal Trade